NASDAQ:XLO | Cash Flow Statement | Xilio Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$6.37M
2026-03-31-$9.53M$344,000.00-$22.34M$556,000.00-$556,000.00$35.71M
2025-12-31$10.36M$323,000.00-$2M$95,000.00-$95,000.00$35.87M
2025-09-30-$16.29M
2025-06-30-$15.84M
2025-03-31-$13.27M$497,000.00$28.98M$22,000.00-$22,000.00$4.83M
2024-12-31-$13.09M$376,000.00-$14.16M$6,000.00-$6,000.00$8.2M
2024-09-30-$14.02M
2024-06-30-$13.93M
2024-03-31-$17.2M$443,000.00-$10.5M$954,000.00
2023-12-31-$17.66M$449,000.00-$13.43M$0.00$0.00-$1.63M
2023-09-30-$16.75M
2023-06-30-$19.36M
2023-03-31-$22.65M$499,000.00-$25.25M$170,000.00-$170,000.00-$1.69M
2022-12-31-$22.47M$489,000.00-$18.22M$509,000.00-$509,000.00-$21,000.00
2022-09-30-$19.79M
2022-06-30-$24.61M
2022-03-31-$21.35M$440,000.00-$20.84M$254,000.00-$254,000.00-$5,000.00
2021-12-31-$19.7M$394,000.00-$17.16M$378,000.00-$378,000.00$115.83M
2021-09-30-$16.25M
2021-06-30-$23.18M
2021-03-31-$16.67M$350,000.00-$22.73M$170,000.00-$170,000.00$144.89M
2020-12-31-$20.77M$341,000.00-$12.71M$108,000.00-$108,000.00$125,000.00
2020-09-30-$14.82M
2020-06-30-$11.51M
2020-03-31-$8.12M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$35.04M$1.54M-$4.99M$518,000.00-$518,000.00$87.78M
2024-12-31-$58.24M$1.64M-$18.38M$36,000.00-$36,000.00$29.2M
2023-12-31-$76.4M$1.9M-$68.62M$486,000.00-$486,000.00-$6.55M
2022-12-31-$88.22M$1.85M-$75.72M$1.87M-$1.87M-$69,000.00
2021-12-31-$75.8M$1.5M-$80.75M$1.1M-$1.1M$260.67M
2020-12-31-$55.22M$1.07M-$36.09M$2.19M-$2.19M$10.03M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.